According to Kringle Pharma latest financial reports the total liabilities of 4884 is $4.13M, an increase of 42.30% to 2022. At the end of 2022 company had $2.90M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Kringle Pharma is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $4.13M | 42.30% |
2022 | $2.90M | 224.00% |
2021 | $896.00K | -19.94% |
2020 | $1.12M | 355.87% |
2019 | $245.49K | 74.84% |
2018 | $140.41K | - |